Evidence map›Paper›PMID 27779248›Full record

ArticleThe pharmacogenomics journal2018

Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation.

P Huezo-Diaz Curtis, C R S Uppugunduri, J Muthukumaran, M A Rezgui, C Peters, P Bader, M Duval, H Bittencourt, Maja Krajinovic, Marc Ansari

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The pharmacogenomics journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01257854 (Polymorphisms and Busulfan Pharmacokinetic Study in Pediatric Transplnatation), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01257854 unknown statusnot on this map

Polymorphisms and Busulfan Pharmacokinetic Study in Pediatric Transplnatation

TypeobservationalSponsorUniversity Hospital, GenevaRan2008 to 2023Enrolled200ConditionsChildren Who Receive a Stem Cell Transplantation With Busulfan IV
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Impact ofPharmaceutics · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 5 countries.

P Huezo-Diaz CurtisDepartment of Pediatrics, Onco-Haematology Unit, Geneva University Hospital, Geneva, Switzerland.
C R S UppugunduriDepartment of Pediatrics, Onco-Haematology Unit, Geneva University Hospital, Geneva, Switzerland.
J MuthukumaranUCIBIO@REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.
M A RezguiCharles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Quebec, Canada.
C PetersSt Anna Children's Hospital, Vienna, Austria.
P BaderUniversity Hospital for Children and Adolescents, Frankfurt/Main, Germany.
M DuvalCharles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Quebec, Canada.
H BittencourtCharles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Quebec, Canada.
Maja KrajinovicCharles-Bruneau Cancer Center, CHU Sainte-Justine, Montreal, Quebec, Canada.
Marc AnsariDepartment of Pediatrics, Onco-Haematology Unit, Geneva University Hospital, Geneva, Switzerland.
Centre Hospitalier Universitaire Sainte-Justine · CAUniversity of Geneva · CHGoethe University Frankfurt · DEUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinusoidal obstruction syndrome (SOS) is a severe complication of hematopoietic stem cell transplantation (HSCT) that can be fatal, often attributed to the conditioning regimen prior to HSCT. We evaluated the association of SOS risk with gene variants in cystathionase (CTH), an enzyme involved in glutathione synthesis, in 76 children receiving intravenous busulfan (Bu) before HSCT. Our results indicated an association with CTHc.1364 G>T (OR

Indexed as

Administration, IntravenousAdolescentAdultBusulfanChildChild, PreschoolCyclophosphamideCystathionine gamma-LyaseFemaleGenetic VariationGenotypeGlutathioneGlutathione TransferaseHematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHumansBusulfanCyclophosphamideCystathionine gamma-LyaseGlutathioneGlutathione Transferase

Identifiers

PMID27779248
PMCPMC5817388
OpenAlexW2538955337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.